343 related articles for article (PubMed ID: 19218811)
1. Evaluation of FITC-induced atopic dermatitis-like disease in NC/Nga mice and BALB/c mice using computer-assisted stereological toolbox, a computer-aided morphometric system.
Hvid M; Jensen HK; Deleuran B; Kemp K; Andersson C; Deleuran M; Vestergaard C
Int Arch Allergy Immunol; 2009; 149(3):188-94. PubMed ID: 19218811
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T cell depletion changes the cytokine environment from a TH1/TH2 response to a TC17-like response in a murine model of atopic dermatitis.
Christensen GB; Hvid M; Kvist PH; Deleuran B; Deleuran M; Vestergaard C; Kemp K
Int Immunopharmacol; 2011 Sep; 11(9):1285-92. PubMed ID: 21530683
[TBL] [Abstract][Full Text] [Related]
3. Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Jang AH; Kim TH; Kim GD; Kim JE; Kim HJ; Kim SS; Jin YH; Park YS; Park CS
Int Immunopharmacol; 2011 Sep; 11(9):1271-7. PubMed ID: 21504802
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice.
Kim DY; Jung JA; Kim TH; Seo SW; Jung SK; Park CS
J Ethnopharmacol; 2009 Apr; 122(3):567-72. PubMed ID: 19429328
[TBL] [Abstract][Full Text] [Related]
5. Induction of atopic eczema/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga mice.
Kang JS; Lee K; Han SB; Ahn JM; Lee H; Han MH; Yoon YD; Yoon WK; Park SK; Kim HM
Int Immunopharmacol; 2006 Oct; 6(10):1616-22. PubMed ID: 16919834
[TBL] [Abstract][Full Text] [Related]
6. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
[TBL] [Abstract][Full Text] [Related]
7. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Cheong KA; Park CD; Lee AY
Scand J Immunol; 2012 May; 75(5):471-8. PubMed ID: 22023698
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice.
Jiang J; Yamaguchi T; Funakushi N; Kuhara T; Fan PS; Ueki R; Suto H; Kase Y; Ikeda S; Ogawa H
J Dermatol Sci; 2009 Oct; 56(1):37-42. PubMed ID: 19647983
[TBL] [Abstract][Full Text] [Related]
10. [Induction of atopic dermatitis-like skin lesion in NC/Nga mice--the influence of the skin barrier destroying solution to the induction of dermatitis].
Unno T; Suto H; Yoshiike T; Ogawa H; Ra C
Arerugi; 2001 Dec; 50(12):1152-62. PubMed ID: 11830999
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
Horiuchi Y; Bae S; Katayama I; Nishioka K
J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
[TBL] [Abstract][Full Text] [Related]
12. Itch-associated scratching contributes to the development of dermatitis and hyperimmunoglobulinaemia E in NC/Nga mice.
Hashimoto Y; Takaoka A; Sugimoto M; Honma Y; Sakurai T; Futaki N; Arai I
Exp Dermatol; 2011 Oct; 20(10):820-5. PubMed ID: 21771100
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice.
Kim TH; Jung JA; Kim GD; Jang AH; Cho JJ; Park YS; Park CS
Int Immunopharmacol; 2010 Oct; 10(10):1310-5. PubMed ID: 20728595
[TBL] [Abstract][Full Text] [Related]
14. Analysis of T cell receptor (TCR) BV-gene clonotypes in NC/Nga mice developing dermatitis resembling human atopic dermatitis.
Matsuoka A; Kato T; Soma Y; Takahama H; Nakamura M; Matsuoka H; Mizoguchi M
J Dermatol Sci; 2005 Apr; 38(1):17-24. PubMed ID: 15795120
[TBL] [Abstract][Full Text] [Related]
15. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
16. Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Kim TH; Jung JA; Kim GD; Jang AH; Ahn HJ; Park YS; Park CS
J Pineal Res; 2009 Nov; 47(4):324-9. PubMed ID: 19817972
[TBL] [Abstract][Full Text] [Related]
17. Role of scratch-induced cutaneous prostaglandin D production on atopic-like scratching behaviour in mice.
Takaoka A; Arai I; Sugimoto M; Futaki N; Sakurai T; Honma Y; Nakaike S
Exp Dermatol; 2007 Apr; 16(4):331-9. PubMed ID: 17359340
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic and prophylactic effects of PUVA photochemotherapy on atopic dermatitis-like lesions in NC/Nga mice.
Miyauchi-Hashimoto H; Okamoto H; Sugihara A; Horio T
Photodermatol Photoimmunol Photomed; 2005 Jun; 21(3):125-30. PubMed ID: 15888128
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor.
Noh SU; Cho EA; Kim HO; Park YM
Int Immunopharmacol; 2008 Sep; 8(9):1172-82. PubMed ID: 18602062
[TBL] [Abstract][Full Text] [Related]
20. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment.
Oshio T; Sasaki Y; Funakoshi-Tago M; Aizu-Yokota E; Sonoda Y; Matsuoka H; Kasahara T
Int Immunopharmacol; 2009 Apr; 9(4):403-11. PubMed ID: 19162238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
